Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancer

NCT06129851 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
90
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Kansas Medical Center

Collaborators